Taiwan Negotiates Supply Of Additional 5 Million H1N1 Vaccine Doses From Novartis
This article was originally published in PharmAsia News
Executive Summary
Taiwan's government has negotiated with Swiss drug maker Novartis to provide another 5 million doses of its H1N1 flu vaccine. Taiwan's Central Epidemic Command Center also has bought more than 2 million courses of antivirals from foreign drug makers to add to its stockpile for treating the flu. With the additional purchase from Novartis, Taiwan expects to have enough vaccine on hand to vaccinate a third of the population. (Click here for more